SCHEMBL5047902

SCHEMBL5047902

Cn1ncc(-c2ccc(F)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.47
SCN4A P35499 1/20 0.46
MET P08581 4/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FYN P06241 1/20 0.38
KDM1A O60341 1/20 0.37
MAPK13 O15264 1/20 0.37
CSNK1D P48730 1/20 0.37
CSNK1E P49674 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21412297 0.80 AOC3 (0.47) AOC3METNPC1RAB9ACHRM2
Ammonia Solution, Strong SCHEMBL28862485 0.80 AOC3 (0.43) AOC3NPC1RAB9ACHRM2CHRM3
SCHEMBL5053616 0.80 AOC3 (0.47) AOC3METNPC1RAB9ACHRM2
SCHEMBL11730368 0.80 KEAP1 (0.55) AOC3NPC1RAB9ACHRM2CHRM3
SCHEMBL5048013 0.80 AOC3 (0.43) AOC3NPC1RAB9ACHRM2CHRM3
SCHEMBL27255898 0.79 EP300 (0.44) AOC3ALDH1A1LMNAKDM1AF2RL3
SCHEMBL23328880 0.77 AOC3 (0.42) AOC3NPC1RAB9ACHRM2CHRM3
SCHEMBL5047974 0.77 AOC3 (0.51) AOC3METNPC1RAB9AALDH1A1
SCHEMBL6967960 0.76 KCNH2 (0.50) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL22918654 0.76 AOC3 (0.50) AOC3CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed